What's in Centro de Investigacao em Saude de Manhica's pipeline?

Centro de Investigacao em Saude de Manhica has 3 drugs in our index: 3 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Centro de Investigacao em Saude de Manhica's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, CalciMedica, Inc., Centers for Disease Control and Prevention, London School of Hygiene and Tropical Medicine, Malaria Consortium, Uganda.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/centro-de-investigacao-em-saude-de-manhica.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Centro de Investigacao em Saude de Manhica — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Centro de Investigacao em Saude de Manhica pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
DHP	DHP	marketed	calcium channel blocker	L-type calcium channels	Cardiovascular
AS-AQ (Carsucam)	AS-AQ (Carsucam)	marketed	Artemisinin-based combination therapy (ACT)	Plasmodium falciparum (multiple parasite targets)	Infectious Disease / Parasitology
AL (Coartem)	AL (Coartem)	marketed	Artemisinin-based combination therapy (ACT)	Parasite heme metabolism; hemozoin formation	Infectious Disease

Therapeutic area mix

Cardiovascular · 1
Infectious Disease · 1
Infectious Disease / Parasitology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 1 shared drug class
CalciMedica, Inc. · 1 shared drug class
Centers for Disease Control and Prevention · 1 shared drug class
London School of Hygiene and Tropical Medicine · 1 shared drug class
Malaria Consortium, Uganda · 1 shared drug class
Ministry of Public Health, Democratic Republic of the Congo · 1 shared drug class
National Institute of Malariology, Parasitology and Entomology, Vietnam · 1 shared drug class
Oxford University Clinical Research Unit, Vietnam · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Centro de Investigacao em Saude de Manhica:

Cite this brief

Drug Landscape (2026). Centro de Investigacao em Saude de Manhica — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/centro-de-investigacao-em-saude-de-manhica. Accessed 2026-05-17.